Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
BP
BP
$109B
| $1.76M | ﹤0.01% |
64,555
+54,620
| +550% | +$1.37M |
|
4027
Mustang Bio
MBIO
$4.07M
| $1.76M | ﹤0.01% |
872
+5
| +0.6% | +$10.7K |
|
4028
DXP Enterprises
DXPE
$2.88B
| $1.76M | ﹤0.01% |
59,459
+44,926
| +309% | +$1.38M |
|
4029
CALL
Community Health Systems
CYH
$413M
| $1.75M | ﹤0.01% |
150,000
-150,000
| -50% | -$1.96M |
|
4030
Hasbro
HAS
$13.3B
| $1.75M | ﹤0.01% |
19,671
-184,468
| -90% | -$17.9M |
|
4031
Consolidated Edison
ED
$39.8B
| $1.75M | ﹤0.01% |
24,166
-31,682
| -57% | -$2.37M |
|
|
BNR
4032
Burning Rock Biotech
BNR
$107M
| $1.75M | ﹤0.01% |
+9,802
| New | +$2.18M |
|
4033
Opko Health
OPK
$1.1B
| $1.75M | ﹤0.01% |
479,760
+45,896
| +11% | +$171K |
|
|
SHCO
4034
DELISTED
Soho House & Co
SHCO
| $1.75M | ﹤0.01% |
+140,555
| New | +$1.76M |
|
4035
PUT
Boston Properties
BXP
$11.1B
| $1.74M | ﹤0.01% |
+16,100
| New | +$1.84M |
|
4036
PUT
Idexx Laboratories
IDXX
$43.7B
| $1.74M | ﹤0.01% |
2,800
-5,000
| -64% | -$3.36M |
|
4037
Quantum-Si Incorporated
QSI
$171M
| $1.74M | ﹤0.01% |
208,722
-2,541,278
| -92% | -$25M |
|
4038
CALL
MannKind Corp
MNKD
$1.27B
| $1.74M | ﹤0.01% |
+400,000
| New | +$1.8M |
|
4039
Century Therapeutics
IPSC
$367M
| $1.74M | ﹤0.01% |
69,024
-112,140
| -62% | -$3.04M |
|
4040
Kadant
KAI
$3.57B
| $1.74M | ﹤0.01% |
8,502
+3,243
| +62% | +$639K |
|
|
AD
4041
Array Digital Infrastructure
AD
$3.11B
| $1.73M | ﹤0.01% |
54,379
-33,629
| -38% | -$1.12M |
|
|
MDWT
4042
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $1.73M | ﹤0.01% |
44,554
-11,233
| -20% | -$436K |
|
4043
International Money Express
IMXI
$437M
| $1.73M | ﹤0.01% |
+103,676
| New | +$1.74M |
|
4044
National Grid
NGG
$79.8B
| $1.73M | ﹤0.01% |
+32,819
| New | +$1.88M |
|
4045
CALL
Seer Inc
SEER
$110M
| $1.73M | ﹤0.01% |
50,000
-50,000
| -50% | -$1.72M |
|
4046
Sherwin-Williams
SHW
$83.7B
| $1.73M | ﹤0.01% |
6,174
-304,424
| -98% | -$89.1M |
|
|
ZENV
4047
DELISTED
Zenvia
ZENV
| $1.72M | ﹤0.01% |
+125,138
| New | +$1.79M |
|
4048
Ring Energy
REI
$378M
| $1.72M | ﹤0.01% |
+583,184
| New | +$1.49M |
|
|
CSGS
4049
DELISTED
CSG Systems International
CSGS
| $1.72M | ﹤0.01% |
35,637
-37,090
| -51% | -$1.74M |
|
4050
InterDigital
IDCC
$8.65B
| $1.72M | ﹤0.01% |
25,330
+5,248
| +26% | +$364K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.